United States COVID-19 Saliva Screening Test Market was valued at USD 1.0 Billion in 2022 and is projected to reach USD 3.2 Billion by 2030, growing at a CAGR of 20.0% from 2024 to 2030.
The COVID-19 Saliva Screening Test Market has gained significant traction since the onset of the pandemic, particularly in the United States. With the need for fast, accurate, and non-invasive testing, saliva-based tests emerged as a game-changer for both individuals and industries. These tests, which require individuals to provide a saliva sample instead of undergoing a nasal swab, have been hailed for their simplicity, cost-effectiveness, and high accuracy, especially in detecting COVID-19 variants.
Industries across the board have shown a growing demand for reliable and rapid testing solutions. Healthcare providers, educational institutions, large-scale employers, and event organizers, in particular, have become key stakeholders in the US COVID-19 Saliva Screening Test Market. The ability to perform regular, large-scale screenings with minimal discomfort has made these tests an appealing option for businesses striving to maintain safe environments while continuing operations.
From a technical perspective, the market has seen various innovations in saliva test kits. Advanced molecular techniques, such as PCR and LAMP, are commonly employed to ensure the accuracy of the results. Some tests also offer results in under an hour, catering to the fast-paced needs of industries such as travel and hospitality, where real-time testing is essential. Moreover, companies offering these tests are continuously improving their products to make them more accessible, with lower costs and user-friendly features.
Regulatory bodies, including the FDA, have played a critical role in ensuring the safety and effectiveness of these tests. As the US COVID-19 Saliva Screening Test Market continues to evolve, industries are likely to adopt these tests more widely, leading to further innovation and improvements in testing protocols. The increasing requirement for these tests also highlights a broader shift towards decentralized healthcare solutions, which are poised to play a key role in post-pandemic recovery strategies.
From airports to factories and schools, COVID-19 Saliva Screening Tests are becoming a cornerstone in the effort to control the spread of the virus. As testing demand continues to rise, the market's potential looks promising, signaling long-term shifts in healthcare and industry practices.
Get an In-Depth Research Analysis of the US COVID-19 Saliva Screening Test Market Size And Forecast [2025-2032]
Â
Psomagen
Inc
ARUP Labs
Vatic Health
MOgene
Fluidigm Corporation
Phosphorus Diagnostics LLC
Quidel Corporation
Abbot Laboratories
FLuroTech Ltd
LumiraDX
Gravity Diagnostics
Ambry Genetics
DxTerity Diagnostics
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US COVID-19 Saliva Screening Test Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US COVID-19 Saliva Screening Test Market
Standalone Tests
Test Kits
Diagnostic Devices
RT-PCR Tests
Antigen Tests
Antibody Tests
Clinical Testing
Self-Testing
Research and Development
Hospitals and Clinics
Laboratories
Home Users
Academic and Research Institutions
Online Sales
Retail Pharmacies
Direct Sales to Healthcare Institutions
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ COVID-19 Saliva Screening Test Market Research Analysis
1. Introduction of the US COVID-19 Saliva Screening Test Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US COVID-19 Saliva Screening Test Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US COVID-19 Saliva Screening Test Market, By Type
6. US COVID-19 Saliva Screening Test Market, By Application
7. US COVID-19 Saliva Screening Test Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US COVID-19 Saliva Screening Test Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/